RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$76.00
−2.29%Forward multiples
Based on analyst estimates
- P/E forward
- 110.49x
- P/E 2026E
- 148.03x
- P/E 2027E
- 85.86x
- P/E 2028E
- 63.97x
- P/S forward
- 2.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.46x
- Price / sales
- 2.64x
- Price / cash flow
- 18.87x
Enterprise value
- Enterprise value
- $7.7B
- EV / sales
- 3.41x
- EV / EBITDA
- 22.93x
- EV / EBIT
- 85.15x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026